Company profile
The CyteCount Rapid Bacterial Detection System | CYTECOM
The CyteCount rapid bacterial detection system. From sample to results in minutes. The CyteCount harnesses bacterial electrophysiology to detect bacteria. Developed & manufactured in the UK by Cytecom.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQ0MTA5NTUyOWFkaXF6a2N4
Published 28 Oct 2024 10:50
Company registered at Companies House
Cytecom develops technology designed to detect both live and bacteria within liquids, using an electrical device.
Cytecom is developing new technology that enables fast and economic detection of microorganisms in a range of samples, e.g. waste water, food etc. The company will be marketing testing devices based on this technology in the near future.
The full impact will be evident once the devices are on the market. At the moment, Cytecom is trialling the technology with commercial partners.
1 May 2024 to 31 Oct 2024
Cytecom have developed a rapid bacteria detector, the CyteCount. We discovered that we could electrically stimulate bacteria and, based on their response to electrical stimulation, determine whether they were alive or dead in seconds, creating the method termed optical electrophysiology. Many methods currently used to detect bacterial vitality rely on gro...
1 Nov 2018 to 29 Feb 2020
Cytecom is an innovative new spin-out company from the University of Warwick with technology that will revolutionise the process of testing products for bacteria. As a result of the ICURe program we were able to guide our scientific discovery process with new information from markets and businesses. This allowed us to identify a clear need for a fast reli...
